Literature DB >> 15339858

CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.

M Sabrina Spano1, Liana Fattore, Gregorio Cossu, Serena Deiana, Paola Fadda, Walter Fratta.   

Abstract

We recently provided evidence for a functional link between cannabinoid and opioid endogenous systems in relapse to heroin-seeking behaviour in rats. In the present study, we aimed at investigating whether the previously observed cross-talk between cannabinoids and opioids could be extended to mechanisms underlying relapse to cannabinoid-seeking behaviour after a prolonged period of abstinence. In rats previously trained to intravenously self-administer the synthetic cannabinoid receptor (CB1) agonist WIN 55,212-2 (12.5 microg kg(-1) inf(-1)) under a fixed ratio (FR1) schedule of reinforcement, noncontingent nonreinforced intraperitoneal (i.p.) priming injections of the previously self-administered CB1 agonist (0.25 and 0.5 mg kg(-1)) as well as heroin (0.5 mg kg(-1)), but not cocaine (10 mg kg(-1)), effectively reinstate cannabinoid-seeking behaviour following 3 weeks of extinction. The selective CB1 receptor antagonist SR 141716A (0.3 mg kg(-1) i.p.) does not reinstate responding when given alone, but completely prevents the cannabinoid-seeking behaviour triggered by WIN 55,212-2 or heroin primings. The nonselective opioid antagonist naloxone (1 mg kg(-1) i.p.) has no effect on operant behaviour per se, but significantly blocks cannabinoid- and heroin-induced reinstatement of cannabinoid-seeking behaviour. These results provide the first evidence of drug-induced reinstatement of cannabinoid-seeking behaviour, and further strengthen previous findings on a cross-talk between the endogenous cannabinoid and opioid systems in relapse mechanisms to drug-seeking.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339858      PMCID: PMC1575345          DOI: 10.1038/sj.bjp.0705932

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  56 in total

1.  CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats.

Authors:  L Fattore; M C Martellotta; G Cossu; M S Mascia; W Fratta
Journal:  Behav Brain Res       Date:  1999-10       Impact factor: 3.332

2.  Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome.

Authors:  T Rubino; P Massi; D Viganò; D Fuzio; D Parolaro
Journal:  Life Sci       Date:  2000-04-21       Impact factor: 5.037

3.  Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse.

Authors:  G Cossu; C Ledent; L Fattore; A Imperato; G A Böhme; M Parmentier; W Fratta
Journal:  Behav Brain Res       Date:  2001-01-08       Impact factor: 3.332

4.  Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect.

Authors:  O Valverde; F Noble; F Beslot; V Daugé; M C Fournié-Zaluski; B P Roques
Journal:  Eur J Neurosci       Date:  2001-05       Impact factor: 3.386

5.  Functional interaction between opioid and cannabinoid receptors in drug self-administration.

Authors:  M Navarro; M R Carrera; W Fratta; O Valverde; G Cossu; L Fattore; J A Chowen; R Gomez; I del Arco; M A Villanua; R Maldonado; G F Koob; F Rodriguez de Fonseca
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

6.  Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice.

Authors:  M S Mascia; M C Obinu; C Ledent; M Parmentier; G A Böhme; A Imperato; W Fratta
Journal:  Eur J Pharmacol       Date:  1999-11-03       Impact factor: 4.432

7.  Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids.

Authors:  A F Hoffman; C R Lupica
Journal:  J Neurophysiol       Date:  2001-01       Impact factor: 2.714

8.  Dissociation of primary and secondary reward-relevant limbic nuclei in an animal model of relapse.

Authors:  J W Grimm; R E See
Journal:  Neuropsychopharmacology       Date:  2000-05       Impact factor: 7.853

9.  Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors.

Authors:  M Shapira; Z Vogel; Y Sarne
Journal:  Cell Mol Neurobiol       Date:  2000-06       Impact factor: 5.046

10.  Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

Authors:  G Tanda; P Munzar; S R Goldberg
Journal:  Nat Neurosci       Date:  2000-11       Impact factor: 24.884

View more
  37 in total

1.  Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.

Authors:  L Fattore; Ms Spano; V Melis; P Fadda; W Fratta
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 2.  Animal models of cannabinoid reward.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

3.  Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats.

Authors:  Lina Yao; Krista McFarland; Peidong Fan; Zhan Jiang; Takashi Ueda; Ivan Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-09       Impact factor: 11.205

Review 4.  Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.

Authors:  Nimish Sidhpura; Loren H Parsons
Journal:  Neuropharmacology       Date:  2011-06-12       Impact factor: 5.250

Review 5.  Addiction and brain reward and antireward pathways.

Authors:  Eliot L Gardner
Journal:  Adv Psychosom Med       Date:  2011-04-19

Review 6.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

7.  Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones.

Authors:  L Fattore; M S Spano; S Altea; P Fadda; W Fratta
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 8.  Role of cues and contexts on drug-seeking behaviour.

Authors:  Christina J Perry; Isabel Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

9.  Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens.

Authors:  Zheng-Xiong Xi; Jeremy G Gilbert; Xiao-Qing Peng; Arlene C Pak; Xia Li; Eliot L Gardner
Journal:  J Neurosci       Date:  2006-08-16       Impact factor: 6.167

Review 10.  Cannabinoid abuse and addiction: Clinical and preclinical findings.

Authors:  L V Panlilio; S R Goldberg; Z Justinova
Journal:  Clin Pharmacol Ther       Date:  2015-05-02       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.